SymBio Pharmaceuticals (TSE:4582) Ending Cash Position : 円0 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is SymBio Pharmaceuticals Ending Cash Position?

SymBio Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 was 円0 Mil.

SymBio Pharmaceuticals's annual Ending Cash Position increased from Dec. 2021 (円3,860 Mil) to Dec. 2022 (円6,283 Mil) and increased from Dec. 2022 (円6,283 Mil) to Dec. 2023 (円6,517 Mil).

SymBio Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for SymBio Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SymBio Pharmaceuticals Ending Cash Position Chart

SymBio Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

3,910.83

3,848.63

3,860.11

6,282.55

6,517.01

SymBio Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

SymBio Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

SymBio Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6282.555	+	234.452
	=	6,517

SymBio Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0

SymBio Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of SymBio Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

SymBio Pharmaceuticals (TSE:4582) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SymBio Pharmaceuticals Ltd (TSE:4582) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

SYMQY:USA

Address

5-23-7 Shimbashi, San-Ei Building, 8th Floor, Minato-ku, Tokyo, JPN, 105-0004

Website

http://www.symbiopharma.com

SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in manufacturing and commercializing drugs for oncology, hematology, and pain management.

SymBio Pharmaceuticals (TSE:4582) Headlines

No Headlines